The Pediatric Anxiety Rating Scale (PARS): Development and Psychometric Properties - 01/09/11
ABSTRACT |
Objective |
To describe the development and psychometric properties of the Pediatric Anxiety Rating Scale (PARS), a clinician-rated instrument for assessing the severity of anxiety symptoms associated with common DSM-IV anxiety disorders (social phobia, separation anxiety disorder, and generalized anxiety disorder) in children.
Method |
As part of a multisite study of the efficacy of fluvoxamine, 128 children (aged 6–17) and their parents were interviewed weekly with the PARS. Data from multiple raters on a subsample of children (using live and videotaped interviews) were used to evaluate interrater reliability. Internal consistency, test-retest reliability, and validity (convergent, divergent) also were evaluated.
Results |
The PARS showed high interrater reliability, adequate test-retest reliability, and fair internal consistency. Convergent and divergent validity were satisfactory. PARS scores were sensitive to treatment and paralleled change in other measures of anxiety symptoms and global improvement.
Conclusions |
The PARS is a useful clinician-rated instrument for assessing pediatric anxiety symptoms, severity, and impairment, particularly in treatment studies. Further study of the psychometric properties is warranted.
Le texte complet de cet article est disponible en PDF.Key Words : anxiety, children, adolescents, rating scales, assessment
Plan
| The study sites and authors are listed at the end of the text. The PARS and instructions for its administration are available via the Article Plus feature on the Journal’s Web site: www.jaacap.com. Supported by contracts from the NIMH to Johns Hopkins University (N01MH60016; PI: Dr. Riddle) and the Research Foundation for Mental Hygiene (N01MH60005; PI: Dr. Greenhill) and Solvay Pharmaceuticals; NIMH grants MH57503 and MH-01391 (Dr. Pine); NIMH RUPP contract N01MH70010 (Dr. McCracken); and National Center for Research Resources/NIH General Clinical Research Center grant M01 RR00052 (Johns Hopkins University School of Medicine). Reprint requests to Dr. Riddle, Division of Child and Adolescent Psychiatry, Johns Hopkins Children’s Center, Room 346, 600 North Wolfe Street, Baltimore, MD 21287-3325; e-mail: mriddle@jhmi.edu. The authors of this report, listed by study site: Mark A. Riddle, M.D., Golda S. Ginsburg, Ph.D., John T. Walkup, M.D., Michael J. Labelarte, M.D., Johns Hopkins University; Daniel S. Pine, M.D., Mark Davies, M.P.H., Laurence Greenhill, M.D., Michael Sweeney, Ph.D., Rachel Klein, Ph.D., Columbia University and New York State Psychiatric Institute; Howard Abikoff, Ph.D., Sabine Hack, M.D., Brian Klee, M.D., New York University; James McCracken, M.D., Lindsey Bergman, Ph.D., John Piacentini, Ph.D., University of California at Los Angeles; John March, M.D., M.P.H., Scott Compton, Ph.D., Duke University; James Robinson, M.E.D., Thomas O’Hara, M.B.A., Sherryl Baker, Ph.D., Nathan Kline Institute; Benedetto Vitiello, M.D., Louise Ritz, M.B.A., Margaret Roper, M.P.H., National Institute of Mental Health. Dr. Riddle accepts responsibility for the overall content and integrity of the manuscript. |
Vol 41 - N° 9
P. 1061-1069 - septembre 2002 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
